Finance

Beta
Lists
Equity sectors
Symbols
Symbols
Price
Change
% Change
Trend
Prev Close
Open
High
Low
Volume
Mkt Cap
SX3P
Consumer Staples
SX3P
Consumer Staples
SX3P
+0.58%
619.21
+3.56
+0.58%
—615.65615.07619.70614.21——
SX6P
Utilities
SX6P
Utilities
SX6P
-3.70%
530.86
-20.38
-3.70%
—551.24548.70548.70530.09——
SX8P
Technology
SX8P
Technology
SX8P
-1.74%
930.62
-16.46
-1.74%
—947.08946.19946.19917.62——
SXAP
Consumer Discretionary
SXAP
Consumer Discretionary
SXAP
-1.87%
456.05
-8.70
-1.87%
—464.75463.99464.64453.17——
SXDP
Health Care
SXDP
Health Care
SXDP
-0.35%
1,090.63
-3.82
-0.35%
—1,094.451,093.531,102.341,089.23——
SXEP
Energy
SXEP
Energy
SXEP
-0.14%
535.34
-0.73
-0.14%
—536.07535.49537.10532.16——
SXFP
Financials
SXFP
Financials
SXFP
-0.53%
890.23
-4.73
-0.53%
—894.96895.33896.45886.07——
SXKP
Communications
SXKP
Communications
SXKP
-1.11%
312.78
-3.52
-1.11%
—316.30317.30317.88312.06——
SXNP
Industrials
SXNP
Industrials
SXNP
-2.47%
1,095.60
-27.75
-2.47%
—1,123.351,118.991,118.991,092.58——
SXPP
Materials
SXPP
Materials
SXPP
-5.11%
818.07
-44.02
-5.11%
—862.09841.63841.63810.46——
OXB:LON
Oxford BioMedica plc
GBX 608.00
-1.78%
(-11.00) 1D
May 15, 5:13:41 PM GMT+1  ·   GBX
All symbols
SymbolPriceChange% Change
Generating top insights for OXB...
Open
GBX 619.00
High
GBX 619.00
Low
GBX 600.00
Mkt. cap
735.20M
Avg. vol.
243.06K
Volume
129.64K
52-wk high
GBX 962.00
52-wk low
GBX 288.50
EPS
-GBX 0.27
Shares outstanding
120.92M
No. of employees
977
News stories
From sources across the web
Profile
Oxford Biomedica is a gene and cell therapy company specialising in the development of gene-based medicines. It is listed on the London Stock Exchange and is a constituent of the FTSE 250 Index. Wikipedia
About Oxford BioMedica plc
CEOFrank Mathias
Employees977
Founded1995
Headquarters-
SectorBiotechnology
Websiteoxb.com
Previous reportsAll values in GBP
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in GBP
Mar 2025
Jun 2025
Sep 2025
Dec 2025
Revenue
36.61M
36.61M
47.76M
47.76M
Cost of goods sold
20.78M
20.78M
30.60M
30.60M
Cost of revenue
20.78M
20.78M
30.60M
30.60M
Research and development expenses
992.00K
992.00K
1.54M
1.54M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
26.93M
26.93M
19.65M
19.65M
Operating expense
27.62M
27.62M
20.93M
20.93M
Total operating expenses
48.40M
48.40M
51.52M
51.52M
Operating income
-11.79M
-11.79M
-3.76M
-3.76M
Other non operating income
-63.50K
-63.50K
-323.00K
-323.00K
EBT including unusual items
-13.02M
-13.02M
-2.95M
-2.95M
EBT excluding unusual items
-13.02M
-13.02M
-7.26M
-7.26M
Income tax expense
423.50K
423.50K
-1.07M
-1.07M
Effective tax rate
-3.25%
-3.25%
36.20%
36.20%
Other operating expenses
-311.50K
-311.50K
-259.50K
-259.50K
Net income
-13.18M
-13.18M
-1.88M
-1.88M
Net profit margin
-36.00%
-36.00%
-3.94%
-3.94%
Earnings per share
-
-
-
-
Interest and investment income
538.00K
538.00K
649.50K
649.50K
Interest expense
-3.38M
-3.38M
-3.55M
-3.55M
Net interest expenses
-2.84M
-2.84M
-2.90M
-2.90M
Depreciation and amortization charges
-
-
-
-
EBITDA
-7.07M
-7.07M
-2.06M
-2.06M
Gain or loss from assets sale
-43.00K
-43.00K
53.00K
53.00K
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer

Research

My tasks
You haven't created a task yet
Your tasks will appear here. Schedule tasks and put Google Finance to work while you're away.
Templates
Watchlist briefing
A daily pre-market analysis of your watchlist
Upcoming Earnings
Upcoming earnings reports in the week
Abnormal Volatility & Volume
Volatility and volume early warning today
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer